Concepedia

Dušanka Martinović Kaliterna

DM

Statistics

Publications

16

Citations

954

H-Index

14

Active since

2001

Affiliations

University of Split(Current)

Klinička bolnica "Sveti Duh"

Dušanka Martinović Kaliterna is an author at University of Split specializing in immunopathology, medicine, and autoimmunity.

Publications per year

2001–2020

16

Publications

16

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

, , +4

Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial

Dinesh Khanna, Celia J. F. Lin, Masataka Kuwana et al. · Arthritis & Rheumatism · 2018 · 33 citations

, , +5

Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis.

Mislav Radić, Dušanka Martinović Kaliterna, Josipa Radić · PubMed · 2010 · 30 citations

, , +10

Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Mislav Radić, Dušanka Martinović Kaliterna, Damir Bonacin et al. · Rheumatology International · 2012 · 29 citations

, , +11

The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.

Mislav Radić, Dušanka Martinović Kaliterna, Dragan Ljutić · PubMed · 2006 · 26 citations

, , +15

1–5 of 16